donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
03613 Beijing Tong Ren Tang Chinese Medicine
12.440
-0.180-1.43%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Turnover
18.31% 1.56B 24.08% 704.03M -8.19% 1.32B -31.01% 567.42M
Operating income
18.31% 1.56B 24.08% 704.03M -8.19% 1.32B -31.01% 567.42M
Cost of sales
-20.44% -436.54M -14.51% -203.87M 13.67% -362.44M 19.76% -178.04M
Operating expenses
-20.44% -436.54M -14.51% -203.87M 13.67% -362.44M 19.76% -178.04M
Gross profit
17.5% 1.12B 28.45% 500.16M -5.91% 952.9M -35.17% 389.38M
Selling expenses
-10.33% -186.37M -16.75% -89.42M 15.16% -168.92M 33.22% -76.6M
Administrative expenses
-- -- -24% -66.67M -- -- 14.35% -53.76M
Special items of operating profit
-35.09% -154.8M -59.65% 3.34M -3783.16% -114.58M 978.39% 8.28M
Operating profit
16.29% 778.46M 29.97% 347.41M 2.67% 669.4M -36.94% 267.3M
Financing income
-79.78% 4.38M -81.19% 2.72M -50.13% 21.65M -34.13% 14.48M
Financing cost
-9.47% -4.71M -12.53% -2.21M -2.21% -4.3M 3.96% -1.96M
Special items of earning before tax
130.35% 261K 115.37% 205K 56.39% -860K -105.23% -1.33M
Earning before tax
13.49% 778.39M 25.01% 348.13M -0.48% 685.9M -37.16% 278.49M
Tax
-7.49% -126.85M -35.39% -57.41M -5.02% -118.01M 41.49% -42.41M
After-tax profit from continuing operations
14.73% 651.54M 23.14% 290.72M -1.56% 567.88M -36.32% 236.08M
Earning after tax
14.73% 651.54M 23.14% 290.72M -1.56% 567.88M -36.32% 236.08M
Minority profit
71.9% 43.71M 147.33% 23.5M 22.62% 25.43M -21.78% 9.5M
Profit attributable to shareholders
12.05% 607.84M 17.94% 267.22M -2.46% 542.46M -36.81% 226.58M
Basic earnings per share
12.31% 0.73 18.52% 0.32 -1.52% 0.65 -37.21% 0.27
Diluted earnings per share
12.31% 0.73 18.52% 0.32 -1.52% 0.65 -37.21% 0.27
Currency Unit
HKDHKDHKDHKD
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
PricewaterhouseCoopers--PricewaterhouseCoopers--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Beijing Tongrentang Chinese Medicine Co., Ltd. is mainly engaged in the production and sale of traditional Chinese medicine. The company and its subsidiaries operate through three major divisions. Hong Kong, China Branch is engaged in selling Chinese medicine products and health products through retail stores, providing Chinese medicine diagnostic services and wholesale Chinese medicine products in Hong Kong, China. It is also engaged in managing brand royalties paid by overseas entities that use the "Tongrentang" brand. The mainland China division distributes Tongrentang Technology and Tongrentang brand products exclusively to non-mainland customers in mainland China. Overseas branches retail and wholesale traditional Chinese medicine products and health products in other overseas countries, and provide Chinese medicine diagnosis and treatment services.
CEO: Yongling Ding
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...